EcoDrugPlus

Presenilin Enhancer, Gamma-Secretase Subunit

Ensembl ID : ENSOMEG00000018640
Gene Symbol: PSENEN
3 Cross references
183 Possible Orthologues:

Presenilin-1-Like

Ensembl ID : ENSOMEG00000021438
Gene Symbol: LOC112148748
3 Cross references
200 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSOMEG00000006758
Gene Symbol: LOC112140744
3 Cross references
250 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSOMEG00000001429
Gene Symbol: PGR
3 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSOMEG00000003396
Gene Symbol: PTGDR2
4 Cross references
135 Possible Orthologues:

Prostaglandin D2 Receptor 2-Like

Ensembl ID : ENSOMEG00000000043
Gene Symbol: LOC112157806
2 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSOMEG00000002924
Gene Symbol: PTGER3
3 Cross references
193 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSOMEG00000012549
Gene Symbol: PTGER3
2 Cross references
193 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSOMEG00000017168
Gene Symbol: LOC112159306
3 Cross references
164 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSOMEG00000006114
Gene Symbol: LOC112137480
3 Cross references
167 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype-Like

Ensembl ID : ENSOMEG00000003371
Gene Symbol: LOC112160198
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSOMEG00000012457
Gene Symbol: LOC112163274
3 Cross references
201 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).